Medicamen Biotech shares zoom 20%, up 40% in two sessions

Despite a decent recovery from its 52-week low, Medicamen Biotech is still 35 percent away from its 52-week high

Related Keywords

United States ,Haridwar ,Uttaranchal ,India ,Shivalik Rasayan ,Drug Administration ,Medicamen Biotech ,United States Food ,Medicamen Biotech Shares ,Hares Of Medicamen Biotech ,Pharma Stocks ,Uzzing Stocks ,